Demographic and pulmonary function data for cystic fibrosis patients and control subjects
| CE (n=19) | Control (n=10) | |
| Age yrs | 30±6 | 27±5 |
| Male/Female | 15/4 | 5/5 |
| BMI | 21.8±3.3# | 25.5±2.0 |
| FEV1 | ||
| L | 1.1±0.35 | – |
| % predicted normal | 28±7 | – |
| Arterial blood gases | ||
| pH | 7.4±0.03 | – |
| Pa,CO2 mmHg | 44.2±7.3 | – |
| Pa,O2 mmHg | 65.6±8.2 | – |
| [HCO3−] mmol·L−1 | 28.3±4.2 | – |
| Sa,O2 | 92.1±3.4 | – |
| Sa,O2 awake % | 87±6*** | 95±2 |
| Pt,CO2 awake mmHg | 41.5±7.1 | 47.0±2.3 |
| 6‐min walk | ||
| Distance m | 407±109¶ | 534±74 |
| Min. Sa,O2 % | 86.6±8.0+ | 93.5±5.0 |
Data are presented as mean±sd unless smemise stated
CF: cystic fibrosis
BMI: body mass index
FEV1: forced expiratory volume in one second
Pa,CO2: arterial carbon dioxide tension
Pa,O2: arterial oxygen tension
Sa,O2: arterial oxygen saturation
Sa,O2 awake: arterial oxygen saturation taken by oximetry white supine before nighttime sleep
Pt,CO2: transcutanous carbon dioxide tension taken supine before nighttime sleep
#: p=0.006
¶: p=0.012
***: p<0.001
+: p=0.008 versus Control